Open AccessMucormycosis - The deadly fungus – A case report with dental perspective
Author(s) -
Rakashree Chakraborty,
Divya Pandya,
Priyanka Dausage,
AshmitaK Chawla
Publication year - 2022
Publication title -
journal of family medicine and primary care
Language(s) - English
Resource type - Journals
eISSN - 2278-7135
pISSN - 2249-4863
DOI - 10.4103/jfmpc.jfmpc_1339_21
Subject(s) - medicine , mucormycosis , fungus , debridement (dental) , mucorales , antifungal , surgical debridement , dermatology , disease , fungal disease , pathology , surgery , biology , botany
Mucormycosis is a fungal infection caused by members of Mucorales and zygomycotic species. These are saprophytes known as Mucormycotina that grow from rotten matter or soils during the decomposition of soil. It has been seen affecting many COVID-19-affected patients recently in India. Mucormycosis can be diagnosed in six different sites depending on the immunological status and the site of the body affected. The six manifestations are rhinocerebral, pulmonary, cutaneous, gastrointestinal, and central nervous system or disseminated forms. Here, we present a dental case of mucormycosis or black fungus disease that has affected an immune-compromised patient who had suffered from COVID-19 2 months ago. Surgical debridement was done and the histopathologic study revealed fungal hyphae. Systemic antifungal therapy was administered that helped the patient to recover in 7-week time.